MedPath

Mindful Breaths: Mindfulness for Young Adult Vaping

Not Applicable
Not yet recruiting
Conditions
Vaping Cessation
Registration Number
NCT06626529
Lead Sponsor
Tulane University
Brief Summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, and preliminary efficacy of mindfulness-based interventions (MBI) as a vaping cessation intervention in young adults aged 18-29 who vape nicotine at least 25 days per month and are interested in cutting down or quitting. The main questions it aims to answer are:

* Can mindfulness practice reduce nicotine cravings in young adults?

* Is mindfulness practice an acceptable and feasible intervention for vaping cessation in this population?

Researchers will compare participants in the mindfulness intervention group to a control group that watches a video with calming music and images to see if mindfulness practice has a greater effect on reducing nicotine cravings.

Participants will:

* Complete a baseline survey and craving cue reactivity assessment.

* Engage in a 10-minute guided mindfulness meditation (intervention group) or view calming music and images (control group).

* Rate their cravings and the acceptability, appropriateness, and feasibility of the intervention after the session.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Young adults aged 18-29 years old
  • Residing in the United States
  • Able to read and speak English
  • Vape nicotine at least 25 days/month,
  • Interested in cutting down or quitting vaping in the next 30 days (rated at least a 5 on a 10-point scale).
Exclusion Criteria
  • Using any nicotine-containing products other than e-cigarettes
  • A current or past Diagnostic and Statistical Manual of Mental Disorders (DSM-5) psychiatric diagnosis of severe mental illness
  • A current DSM diagnosis of substance use disorders other than tobacco use disorder
  • Involved in regular mindful practice
  • Undergoing current smoking/vaping cessation treatment (counseling and/or medication)
  • Taking any medications that may potentially affect nicotine craving, consumption, or mood within the past 30 days.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
SatisfactionWithin ten minutes after the completion of a single 10-minute guided meditation session

Satisfaction with the mindfulness intervention will be rated on a scale of 1-5, with a higher score indicating higher satisfaction.

Intervention appealWithin ten minutes after the completion of a single 10-minute guided meditation session

Intervention appeal will be rated on a scale of 1-5, with a higher score indicating greater appeal.

Intervention appropriatenessWithin ten minutes after the completion of a single 10-minute guided meditation session

Intervention appropriateness will be rated on a scale of 1-5, with a higher score indicating greater appropriateness.

Intervention feasibilityWithin ten minutes after the completion of a single 10-minute guided meditation session

Intervention feasibility will be rated on a scale of 1-5, with a higher score indicating higher feasibility.

Perceived effectivenessWithin ten minutes after the completion of a single 10-minute guided meditation session

Perceived intervention effectiveness will be rated on a scale of 1-5, with a higher score indicating greater effectiveness.

Likelihood to continue mindfulness practiceWithin ten minutes after the completion of a single 10-minute guided meditation session

The likelihood of continuing the mindfulness practice will be rated on a scale of 1-5, with a higher score indicating a higher likelihood of continuing the mindfulness practice.

Secondary Outcome Measures
NameTimeMethod
CravingWithin 20 minutes before and after a ten minute guided mindfulness meditation practice.

Craving for e-cigarettes will be measured with the adapted Visual Analog Craving Scale before and after each cue and the intervention/control to assess their craving intensity. Participants rate craving intensity by selecting a position along a line anchored on the left by "not at all" and on the right by "more than ever."

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.